Multiple Sclerosis
FY23 Investigator-Initiated Research Award - Correlates of Disease Option
The list of Fiscal Year 2023 Multiple Sclerosis Research Program Clinical Trial Award - Funding Level 2 applications recommended for funding is for informational purposes only. Identification on the list of applications recommended for funding is not intended to either confer a right to funding nor does it guarantee funding. The award of federal funds to support any of these applications is contingent upon successful negotiations and applicable federal policy.
Institution | Principal Investigator |
---|---|
University of Kansas Medical Center Research Institute, Inc. | Catherine Siengsukon |
Last updated Friday, March 8, 2024